Active Lifestyle Intervention in Anorexia Nervosa: a Comprehensive Study
Key facts
- Who runs it
- University of Oviedo
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 48 people, planned
- Started
- 25 May 2022
- Ended
- 30 Nov 2025
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Progressive Resistance Exercise
- Record updated
- 10 March 2025
Who can take part
- Age
- 14 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Patients:
- Patients with a diagnosis of AN (any subtype)
- BMI >14kg/m2
- Under treatment at the Regional Eating Disorders Unit at the Area IV and V of the Principality of Asturias
- After acute treatment (total or partial hospitalization or other acute treatment regime following the recommendation of the medical team)
- Healthy Controls:
- Meet the physical activity recommendations of the World Health Organization for the age group and sex
Who cannot take part
- Taking prescribed medications while participating in the project
- Suffer from metabolic, pulmonary or cardiovascular disease
- Suffer from serious organic disease
- Patients:
- Contraindications to perform the evaluations proposed in this project
- Unmanaged dysfunctional or compulsive exercise
- Other criteria that, in the opinion of the medical team, prioritize the patient's health (i.e., psychological instability, substance abuse)
- Healthy Controls:
- Have contraindications to perform the proposed assessments or intervention
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this study is to perform a comprehensive analysis of varied health markers and analyze the impact of lifestyle interventions on the prognosis of anorexia nervosa (AN) patients. In addition, this study aims to determine if biomarker analysis can be used as clinical outcomes for disease prognosis long-term and support individualized treatment strategies in female patients with AN during the post-hospitalization phase.
Read full original descriptionShow less
The main questions it aims to answer are:
* What are the miRs and microbiota profiles associated with AN, and how are they linked to other clinical markers? * How does a lifestyle intervention (exercise with nutritional support) affect biomarkers and clinical markers during the first three months after hospitalization? * What are the dynamics and associations of biomarkers, including gut microbiota, and how do they relate to critical events during the six months after hospitalization? * What is the perceived effect of participating in a healthy lifestyle program for patients, families, and professionals involved in the care of these patients?
Participants will:
* Undergo analysis of biomarkers and gut microbiota associated with AN. * Participate in a lifestyle intervention program involving exercise during the first three months post-hospitalization. * Provide samples for biomarker and gut microbiota mapping over a six-month period. * Share feedback on their perceived experience in the lifestyle program through interviews or surveys.
Researchers will compare biomarker and gut microbiota and the effects of the intervention to determine if a lifestyle exercise intervention can lead to better outcomes, and analyze its potential to individualized care strategies.
The 3 groups in the trial
- AN-InterventionTreatment being tested
Patient enrolled in the exercise intervention group
Treatment: Progressive Resistance Exercise
- AN-ControlNo study treatment, for comparison
Patient enrolled in the non-exercise group
- H-ControlNo study treatment, for comparison
Healthy controls in the non-exercise group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- DiANa Project: Uncovering the Relationship Between MircroRNA Expression, Gut Microbiota and Prognosis in Patients with Anorexia Nervosa.
- Record updated
- 10 March 2025